Officials in some countries recommend just one Pfizer shot for children; FDA places hold on Allogene’s cell therapy trial; Biden’s biomedical research agency cut from social spending package.
Five things for health marketers to know: Friday, October 8, 2021, Sponsored by Calcium
J&J to seek FDA authorization for booster shot; GlaxoSmithKline to send 10,000 doses of COVID-19 treatment to Canada; Researchers find targeted brain stimulation may treat depression.
Five things for health marketers to know: Monday, October 4, 2021
Merck’s COVID-19 pill reduces risk of hospitalization and death by 50%; study finds drop in vaping and e-cigarette product use in 2021; FDA issues draft guidance on using real-world evidence, including electronic health records and other medical records.
Five things for health marketers to know: Friday, October 1, 2021
United Airlines to begin firing unvaccinated employees; Biogen and Eisai seek fast approval for Alzheimer’s drug lecanemab; Head of CDC COVID response steps down.
Five things for health marketers to know: Tuesday, September 28, 2021
New York’s healthcare employee vax mandate goes into effect; Schools struggle to implement COVID testing protocols; Biohaven’s verdiperstat fails to reach endpoints in Phase III trial.